• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

14 Drugs Approved for Primary Care in 2020


Get a quick look at 14 of the many FDA-approved drugs in 2020 for conditions commonly seen in primary care.

The year 2020 has been one-of-a-kind as the novel coronavirus disease 2019 (COVID-19) began to spread globally just after the new year and "social distancing" has become everyday language.

Just like this unique year, there were a number of drugs approved by the US Food and Drug Administration (FDA) that were first-in-class or novel in another way in all 4 quarters of 2020. For example, the first and only FDA-approved COVID-19 treatment; the first adjuvanted, cell-based flu vaccine for use in persons aged ≥6 months; and a first-in-class adenosine triphosphate-citrate lyase inhibitor to treat heterozygous familial hypercholesterolemia. In the slides below, we recap these drugs and 11 more to prepare primary care clinicians for 2021.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
© 2024 MJH Life Sciences

All rights reserved.